Healthy volunteers help uncover drug interaction risks
NCT ID NCT05248945
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how taking multiple doses of carbamazepine changes the way the body processes a single dose of evobrutinib. Fourteen healthy adults participated, staying at a research unit for 20 days. The goal was to measure drug levels in the blood and check for side effects. This was a drug interaction study, not a treatment for any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nuvisan GmbH
Neu-Ulm, Bavaria, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test